Lauren Sabella

Lauren Sabella has a strong background in the pharmaceutical industry, with extensive experience in executive and leadership roles. Lauren currently serves as the Chief Operating Officer at MannKind Corporation since March 2023. Prior to this, they were the Board Chair at Solaxa starting from November 2022. From October 2022 to April 2023, Sabella worked as the Principal at LS Consulting Group. Before joining LS Consulting Group, they held the position of Chief Operating Officer at Acorda Therapeutics, Inc. from June 2021 to October 2022, and also served as the Chief Commercial Officer from January 2010 to September 2021. Before that, they worked as a Principal at Tugboat Consulting Group from January 2009 to February 2010. Sabella's earlier experiences include working as the VP Commercial Development at Altus Pharma from May 2006 to August 2008, and as the VP Sales at Boehringer Ingelheim from an unspecified start date to 2006, and as the Executive Director of Marketing/Respiratory Franchise from an unspecified start date to October 2002.

Lauren Sabella attended Hofstra University, with no specified start or end year, and did not receive a degree or specify a field of study.